By Jeffrey W. Lawrence and Robert K. Jenner Pharmaceutical companies occupy a unique position, particularly in California. They benefit from patent protections and a five-year exclusivity period that can generate billions in revenue. At the same time, California law limits strict liability design defect claims for prescription drugs under Brown v. Superior Court. Together, those …
A Firm Rooted in the Heart of Baltimore As a law firm deeply ingrained in the fabric of Baltimore City, with lawyers who not only work but live and breathe the air of this vibrant community, the recent tragedy at the Francis Scott Key Bridge has hit close to home. The incident on Tuesday, March …
Gilead Sciences, a California biotech company, asked the California Court of Appeal to immunize it from liability for its decision to withhold a safer product from its customers. Gilead believed it had no duty of care to consumers for any liability whatsoever if the product at issue was not defective. Gilead was wrong, and in …
We were greatly disappointed to learn that the United States Court of Appeals for the First Circuit has denied the plaintiffs’ appeal in the Zofran litigation. This ruling upheld the MDL judge’s decision dismissing the cases under the doctrine of “clear evidence preemption.” As a result, after eight years of fighting on behalf of injured …
As you may recall, in July 2021, Exactech issued an urgent worldwide recall regarding its Connexion GXL hip implant due to the inserts being stored in “non-conforming” vacuum bags. As stated in the recall letter – in Exactech’s own words – the consequence of the defective bags is there is: Increased oxygen diffusion to the …
President Biden signed the PACT Act today after Senate Republicans relented to pressure from veterans groups and activists. The Act gives Camp Lejeune victims a 2-year deadline from today to file their civil lawsuit. This means that all Camp Lejeune victims will have until August 10, 2024, to bring their claims under the Act. From …
Recap of Zofran MDL By way of recap, on June 1, 2021, Judge Saylor, the federal court judge overseeing the Zofran multi-district litigation, granted the GSK’s motion for summary judgment on the issue of federal preemption. The core of Judge Saylor’s reasoning is that Judge Saylor believed that there was “clear evidence” that had GSK …
This client portal is for Jenner Law clients and others who have been given authorized access. The material presented is confidential and protected by the Attorney Client Privilege and Attorney Work Product Doctrine. By entering the portal, you agree that you are authorized to have access to this information and that you will keep this information confidential and secure.
This client portal is for Jenner Law clients and others who have been given authorized access. The material presented is confidential and protected by the Attorney Client Privilege and Attorney Work Product Doctrine. By entering the portal, you agree that you are authorized to have access to this information and that you will keep this information confidential and secure.